Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Schein

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Critical Care Medicine|April 11, 2007
Declining standardized mortality ratios: how we treat or whom we treat?Andrew A Quartin, Roland M H Schein
American Journal of Surgery|January 11, 2003
Risk-benefit analysis for drotrecogin alfa (activated)Roland M H Schein, Gary T Kinasewitz
Critical Care Medicine|July 9, 2005
Acute respiratory distress syndrome and long-term outcomes: what should we follow?Roland M H Schein, Andrew A Quartin
Critical Care Medicine|June 10, 2003
Acute lung injury: is the intensive care unit the tip of the iceberg?Andrew A Quartin, Roland M H Schein
Critical Care Medicine|April 19, 2012
Race and respiratory failure: we need to learn moreRoland M H Schein, Andrew A Quartin
Annals of Internal Medicine|November 20, 2008
What conclusions should be drawn between critical care physician management and patient mortality in the intensive care unit?Andrew A Quartin, Roland M H Schein, Cynthia M Cely
Intensive Care Medicine|November 6, 2016
The new sepsis consensus definitions: the good, the bad and the uglyCharles L Sprung, Roland M H Schein, Robert A Balk
Critical Care (London, England)|April 27, 2012
Risk of contrast induced nephropathy in the critically ill: a prospective, case matched studyCynthia M Cely, Roland M H Schein, Andrew A Quartin
Critical Care Medicine|October 29, 2013
Does iodinated radiocontrast material pose an appreciable risk for kidney injury in the critically ill?Andrew A Quartin, Roland M H Schein, Cynthia M Cely
Critical Care Medicine|October 30, 2016
To SIRS With Love-An Open LetterCharles L Sprung, Roland M H Schein, Robert A Balk
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Critical Care Medicine|April 11, 2007
Declining standardized mortality ratios: how we treat or whom we treat?Andrew A Quartin, Roland M H Schein
American Journal of Surgery|January 11, 2003
Risk-benefit analysis for drotrecogin alfa (activated)Roland M H Schein, Gary T Kinasewitz
Critical Care Medicine|July 9, 2005
Acute respiratory distress syndrome and long-term outcomes: what should we follow?Roland M H Schein, Andrew A Quartin
Critical Care Medicine|June 10, 2003
Acute lung injury: is the intensive care unit the tip of the iceberg?Andrew A Quartin, Roland M H Schein
Critical Care Medicine|April 19, 2012
Race and respiratory failure: we need to learn moreRoland M H Schein, Andrew A Quartin
Annals of Internal Medicine|November 20, 2008
What conclusions should be drawn between critical care physician management and patient mortality in the intensive care unit?Andrew A Quartin, Roland M H Schein, Cynthia M Cely
Intensive Care Medicine|November 6, 2016
The new sepsis consensus definitions: the good, the bad and the uglyCharles L Sprung, Roland M H Schein, Robert A Balk
Critical Care (London, England)|April 27, 2012
Risk of contrast induced nephropathy in the critically ill: a prospective, case matched studyCynthia M Cely, Roland M H Schein, Andrew A Quartin
Critical Care Medicine|October 29, 2013
Does iodinated radiocontrast material pose an appreciable risk for kidney injury in the critically ill?Andrew A Quartin, Roland M H Schein, Cynthia M Cely
Critical Care Medicine|October 30, 2016
To SIRS With Love-An Open LetterCharles L Sprung, Roland M H Schein, Robert A Balk
Pageof 3